[CAR 巨噬细胞在恶性血液病中的研究进展]。

Q3 Medicine

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Pub Date : 2024-04-14 DOI:10.3760/cma.j.cn121090-20231103-00248

R B Zheng, Y Xiao

{"title":"[CAR 巨噬细胞在恶性血液病中的研究进展]。","authors":"R B Zheng, Y Xiao","doi":"10.3760/cma.j.cn121090-20231103-00248","DOIUrl":null,"url":null,"abstract":"This article reviews the development history of chimeric antigen receptor macrophage (CAR-M) therapy, discusses its application in malignant hematologic diseases, introduces related clinical trials, analyzes the advantages and challenges faced by CAR-M therapy in clinical application, and looks forward to its future use in the treatment of malignant hematologic diseases.","PeriodicalId":24016,"journal":{"name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Research progress of CAR-macrophages in malignant hematological diseases].\",\"authors\":\"R B Zheng, Y Xiao\",\"doi\":\"10.3760/cma.j.cn121090-20231103-00248\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This article reviews the development history of chimeric antigen receptor macrophage (CAR-M) therapy, discusses its application in malignant hematologic diseases, introduces related clinical trials, analyzes the advantages and challenges faced by CAR-M therapy in clinical application, and looks forward to its future use in the treatment of malignant hematologic diseases.\",\"PeriodicalId\":24016,\"journal\":{\"name\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/cma.j.cn121090-20231103-00248\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn121090-20231103-00248","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

本文回顾了嵌合抗原受体巨噬细胞（CAR-M）疗法的发展历程，探讨了其在恶性血液病中的应用，介绍了相关临床试验，分析了CAR-M疗法在临床应用中的优势和面临的挑战，并展望了其在恶性血液病治疗中的未来应用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Research progress of CAR-macrophages in malignant hematological diseases].

This article reviews the development history of chimeric antigen receptor macrophage (CAR-M) therapy, discusses its application in malignant hematologic diseases, introduces related clinical trials, analyzes the advantages and challenges faced by CAR-M therapy in clinical application, and looks forward to its future use in the treatment of malignant hematologic diseases.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

100